Jay Trautman is a scientist and entrepreneur who, over the last decade, co-founded and is a Director of Invenio Imaging, Vedere Bio II (a spin out of Vedere Bio, which was acquired by Novartis in 2020), Aratome, and Photoswitch Biosciences. Jay started his career at Bell Labs, was an executive at Cytokinetics (CYTK) and at Amersham, which acquired his first start-up (Praelux). He earned his PhD in Chemistry from Cornell University.